BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 113.51 USD 0.38%
Market Cap: 27.4B USD
Have any thoughts about
BioNTech SE?
Write Note

EV/OCF
Enterprise Value to OCF

6.3
Current
1.6
Median
5.9
Industry
Higher than median
Higher than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
6.3
=
Enterprise Value
10B USD
/
Operating Cash Flow
1.5B EUR
All Countries
Close
Market Cap EV/OCF
DE
BioNTech SE
NASDAQ:BNTX
27.2B USD 6.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 691.7
US
Abbvie Inc
NYSE:ABBV
315.2B USD 22.2
US
Amgen Inc
NASDAQ:AMGN
141.9B USD 26.1
US
Gilead Sciences Inc
NASDAQ:GILD
116.4B USD 11.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.5B USD -114.8
US
Epizyme Inc
F:EPE
94.1B EUR -469.8
AU
CSL Ltd
ASX:CSL
135.7B AUD 34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 16.9
US
Seagen Inc
F:SGT
39.3B EUR -73.5
NL
argenx SE
XBRU:ARGX
36B EUR -130.9

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More